Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
VIVXF AVIVAGEN INC
0.0630.0000.00%
YOY
Do not show
Hide blank lines
(Q3)2022/07/31(Q2)2022/04/30(Q1)2022/01/31(FY)2021/10/31
Total revenue
-90.39% 48.61K -44.59% 88.44K 3.50% 271.16K -99.90% 1.3M
Operating revenue
-90.39% 48.61K -44.59% 88.44K 3.50% 271.16K -99.90% 1.3M
Cost of revenue
-90.91% 26.68K -38.43% 60.84K -7.84% 146.43K -99.87% 761.65K
Gross profit
-89.67% 21.93K -54.60% 27.6K 20.97% 124.73K -99.93% 534.34K
Operating expense
15.46% 1.5M 10.70% 1.34M -54.44% 447.43K -99.66% 4.64M
Selling and administrative expenses
7.70% 1.48M 11.42% 1.33M -55.53% 432.01K -99.55% 4.69M
-General and administrative expense
7.70% 1.48M 11.42% 1.33M -55.53% 432.01K -98.42% 4.69M
Depreciation amortization depletion
-28.49% 20.36K -40.19% 20.36K -21.82% 26.42K -- 124.77K
-Depreciation and amortization
-28.49% 20.36K -40.19% 20.36K -21.82% 26.42K -- 124.77K
Other operating expenses
95.36% -5K 34.74% -12.5K 52.74% -11K -- -171.45K
Operating profit
-36.07% -1.47M -14.15% -1.31M 63.29% -322.71K 99.32% -4.11M
Net non-operating interest income expense
-1.66% -426.99K 101.03% 10.49K -21.61% -452.79K -109.08% -2.25M
Non-operating interest income
-91.73% 371 -- 0 -44.35% 133 -99.98% 4.69K
Non-operating interest expense
0.67% 427.36K 25.87% 449.23K 21.57% 452.93K -- 1.59M
Total other finance cost
-- -- -169.11% -459.72K -- -- -- 665.2K
Other net income (expense)
-5,082.36% -777.35K -100.06% -40K
Earnings from equity interest
-- 0 -- 0 -- 0 -- -40K
Special income (charges)
-- -- -- -- -- -777.35K -- --
-Write off
-- -- -- -- -- 777.35K -- --
Income before tax
-26.45% -1.9M 40.68% -1.3M -22.63% -1.55M 98.76% -6.39M
Income tax
0 0 0 0
Net income
-26.45% -1.9M 40.68% -1.3M -22.63% -1.55M 98.76% -6.39M
Net income continuous Operations
-26.45% -1.9M 40.68% -1.3M -22.63% -1.55M 98.76% -6.39M
Minority interest income
Net income attributable to the parent company
-26.45% -1.9M 40.68% -1.3M -22.63% -1.55M 98.76% -6.39M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-26.45% -1.9M 40.68% -1.3M -22.63% -1.55M 98.76% -6.39M
Basic earnings per share
0.00% -0.03 50.00% -0.02 0.00% -0.03 88.63% -0.12
Diluted earnings per share
0.00% -0.03 50.00% -0.02 0.00% -0.03 88.63% -0.12
Dividend per share
Currency Unit
CADCADCADCAD
Audit Opinions
------Unqualified Opinion with Explanation

FY: Financial Year Annual Report, which is equivalent to the 10-K file disclosed by the listed company to the SEC.

Q: Quarterly report, which is equivalent to the 10-Q file disclosed by the listed company to the SEC, where Q1, Q2, Q3, and Q4 are single quarterly reports with a span of 3 months; Q6 and Q9 are cumulative quarterly reports, and Q6 is 6 months , Q9 is 9 months.

The MOM data from the Quarterly report,MOM=(current period - last period)/last period *100%

Company Overview More
Avivagen, Inc. engages in the development and commercialization of products for livestock. Its products include OxC-beta Livestock, Vivamune Vital Health Chews and Oximunol Chewable Tablets. The company was founded by Janusz Daroszewsk and Graham W. Burton on August 4, 2005 and is headquartered in Ottawa, Canada.
CEO: Mr. Kym G.F. Anthony
Market: Pink Market
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist